Very Low Eosinophil Count in an Asymptomatic Patient
In an asymptomatic patient with very low eosinophils (eosinopenia), the most likely explanations are acute stress/corticosteroid effect, underlying hematologic malignancy (particularly acute myeloid leukemia or myelodysplastic syndrome), or rarely, an autoimmune process targeting eosinophils.
Understanding the Clinical Context
While the provided guidelines focus extensively on hypereosinophilia and eosinophilia-associated disorders 1, the question addresses the opposite scenario—eosinopenia. Research evidence demonstrates that risks of hematological malignancies increase not only with elevated eosinophil counts but also when counts approach zero 2. Specifically, low eosinophil counts associate relatively more with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), whereas elevated counts associate more with myeloproliferative neoplasms 2.
Most Common Causes of Eosinopenia
1. Acute Stress Response or Corticosteroid Exposure
- Most common benign cause
- Endogenous cortisol surge or exogenous corticosteroid administration
- Check medication history (including topical, inhaled, or systemic steroids)
- Recent acute illness, surgery, or physiologic stress
2. Hematologic Malignancies
The hematology-oncology referral suggests concern for:
- Acute myeloid leukemia (AML): Eosinopenia may precede or accompany diagnosis 2
- Myelodysplastic syndromes (MDS): Associated with low eosinophil counts 2
- Complete blood count should be reviewed for other cytopenias, blasts, or dysplastic features 3
3. Rare Autoimmune Eosinophil Deficiency
- Extremely rare: IgG-mediated cytotoxic destruction of eosinophils 4
- May paradoxically present with allergic manifestations (urticaria, rhinitis) 4
- Associated with immunodeficiency syndromes, particularly with thymoma and hypogammaglobulinemia 5
Diagnostic Approach
Immediate evaluation should include:
- Complete blood count with differential: Assess for pancytopenia, other lineage abnormalities, circulating blasts
- Peripheral blood smear review: Look for dysplasia, immature cells, blast forms
- Medication reconciliation: Document all corticosteroid exposures (systemic, inhaled, topical, intra-articular)
- Recent illness history: Acute infections, surgical procedures, severe stress
If initial workup is unrevealing:
- Bone marrow biopsy with cytogenetics and molecular studies: Essential if other cytopenias present or if persistent unexplained eosinopenia 3
- Immunoglobulin levels: If suspecting immunodeficiency-associated eosinopenia 5
- Flow cytometry: To evaluate for abnormal T-cell populations or clonal disorders
Key Clinical Pitfalls
Don't dismiss isolated eosinopenia as benign: The U-shaped risk curve means that very low counts carry similar malignancy risk as elevated counts 2, 6
Asymptomatic doesn't mean benign: Many hematologic malignancies present with laboratory abnormalities before symptoms develop
Check for "hidden" corticosteroid exposure: Patients may not report topical, inhaled, or over-the-counter preparations containing steroids
Serial monitoring is essential: If no immediate cause identified, repeat CBC in 2-4 weeks to assess persistence versus transient phenomenon
When to Escalate Concern
Immediate bone marrow evaluation warranted if:
- Any other cytopenias present (anemia, thrombocytopenia, neutropenia)
- Circulating blasts or dysplastic cells on smear
- Persistent eosinopenia >4 weeks without identifiable cause
- Constitutional symptoms develop (fever, night sweats, weight loss)
The hematology-oncology referral is appropriate given that eosinopenia carries similar malignancy risk to eosinophilia 2, and the specialist can systematically exclude myeloid neoplasms while monitoring for evolution of disease.